Skip to Main Content

Author Details

David A Solomon
University of California san francisco
2003
155
42
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37978951Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.J Clin Oncol2024
37978951Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.J Clin Oncol2024
36271929Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.Acta Neuropathol2023
36271929Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.Acta Neuropathol2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37944590Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Nat Med2023
37821623Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis.Acta Neuropathol2023
38079020"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.Acta Neuropathol2023
36897259Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.Blood Adv2023
37436963Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.Neuro Oncol2023
36993741Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Res Sq2023
36730676Patterns of Extraneural Metastases in Children With Ependymoma.J Pediatr Hematol Oncol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37292686Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.Res Sq2023
36723772Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.Acta Neuropathol2023
38079020"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.Acta Neuropathol2023
37944590Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Nat Med2023
37821623Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis.Acta Neuropathol2023
37292686Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.Res Sq2023
36993741Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.Res Sq2023
37436963Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.Neuro Oncol2023
36723772Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.Acta Neuropathol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36897259Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.Blood Adv2023
36730676Patterns of Extraneural Metastases in Children With Ependymoma.J Pediatr Hematol Oncol2023
34821426Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.Brain Pathol2022
35395677Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.Neuro Oncol2022
35908833EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.Neuro Oncol2022
35835335Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.Ophthalmology2022
35703914Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.J Neuropathol Exp Neurol2022
35511927CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.Clin Cancer Res2022
35759011Intratumor and informatic heterogeneity influence meningioma molecular classification.Acta Neuropathol2022
35945463Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.Acta Neuropathol2022
35611269Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma.Neurooncol Adv2022
36114166Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.Nat Commun2022
35534562Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.Nat Genet2022
36539501A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets.Nat Cancer2022
34910220Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.Acta Neuropathol2022
35157770A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.Blood Adv2022
34825267EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma.Acta Neuropathol2022
34821426Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.Brain Pathol2022
35287169PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications.Neuro Oncol2022
35103816High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.Acta Neuropathol2022
35511927CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.Clin Cancer Res2022
35703914Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.J Neuropathol Exp Neurol2022
35611269Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma.Neurooncol Adv2022
35835335Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.Ophthalmology2022
35534562Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.Nat Genet2022
35759011Intratumor and informatic heterogeneity influence meningioma molecular classification.Acta Neuropathol2022
  • 1 - 50 of 310

Recommended Authors

College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 5
Children's Hospital Los Angeles
Career Start Year 2014
Number of shared co-authors 24
Institute Curie
Career Start Year 2014
Number of shared co-authors 47
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 33
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 2
Institut Curie Hospital
Career Start Year 2010
Number of shared co-authors 4
University of Texas MD Anderson Cancer Center Houston
Career Start Year 2009
Number of shared co-authors 55
St Jude Children's Research Hospital
Career Start Year 2009
Number of shared co-authors 73
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 42
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 23
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 53
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Career Start Year 2007
Number of shared co-authors 83
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 6
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 9
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 36
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 32
University of Toronto
Career Start Year 2003
Number of shared co-authors 76
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 9
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 10
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Career Start Year 2001
Number of shared co-authors 57
S. Anna General Hospital
Career Start Year 2000
Number of shared co-authors 26
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 14
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 44
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 21
Erasmus MC Cancer Institute
Career Start Year 1995
Number of shared co-authors 52
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
Career Start Year 1994
Number of shared co-authors 60
National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 9
Institute of Neuropathology, Heinrich Heine University
Career Start Year 1993
Number of shared co-authors 37
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Career Start Year 1990
Number of shared co-authors 74
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 38

Collaborators

University of California san francisco
Co-authored papers 71
University of California san francisco
Co-authored papers 36
University of California san francisco
Co-authored papers 30
University of California san francisco
Co-authored papers 24
University of California San Francisco
Co-authored papers 23
Co-authored papers 22
University of California san francisco
Co-authored papers 19
University Children's Hospital Zurich
Co-authored papers 18
University of California san francisco
Co-authored papers 18
University of California san francisco
Co-authored papers 17
Co-authored papers 17
Children's Hospital of Philadelphia
Co-authored papers 16
Co-authored papers 16
University of California san francisco
Co-authored papers 14
University of California san francisco
Co-authored papers 13
Co-authored papers 12
University of California San Francisco
Co-authored papers 11
University of California san francisco
Co-authored papers 10
Co-authored papers 10
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 10
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 9
University of California San Francisco
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 8
Feinberg School of Medicine, Northwestern University
Co-authored papers 8
Oregon Health & Science University
Co-authored papers 7
University of California san francisco
Co-authored papers 7
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 7
Co-authored papers 7